EHDEN project wraps-up: paves way for EHDEN Foundation

  The EHDEN project, which launched in November 2018, wrapped-up its initial phase at a two-day event on 9/10 October in Barcelona. The overarching theme of Day 1 was “celebration” in which a large group of the EHDEN Community consisting of Consortium Members, SMEs, and Data Partners came together to look back at EHDEN’s many … Read more

DARWIN EU® welcomes first data partners

EMA has selected the first set of data partners to collaborate with DARWIN EU®, the Data Analysis and Real-World Interrogation Network. The data available to these partners will be used for studies to generate real-world evidence that will support scientific evaluations and regulatory decision making. Real-world evidence refers to information derived from analysis of real-world data, … Read more

Regulators are formally adopting real world evidence, when will health technology assessment?

On Monday 31st October, NICE hosted a virtual workshop entitled ‘Regulators are formally adopting real world evidence, when will health technology assessment?’. It was organised as part of our work within the Innovative Medicines Initiative grant-funded project European Health Data & Evidence Network (EHDEN), in collaboration with GetReal Institute. The half-day workshop, moderated by Dr … Read more

EHDEN/OHDSI Feature in COVID-19 Real-World Evidence Primer

COVID-19 was declared a pandemic by the WHO in March of 2020 and EHDEN was formally launched in November 2018. With a solid foundation of Data Partners in place by early 2020, and since then, EHDEN has been collaborating with OHDSI (Observational Health Data Science and Informatics), our growing base of Data Partners, and other … Read more

Series 1 EHDEN Academy Courses for Non-Experts Complete

  With module 3 now posted, EHDEN (European Health Data & Evidence Network), together with the European Patients’ Forum, has completed its initial series of easy-to-understand, animated courses for non-experts as part of the EHDEN Academy course offering. These three introductory courses are designed to familiarise non-experts with the basics of health data in terms … Read more

European Patients’ Forum & EHDEN launch 2nd video course on real world health data management for non-experts on EHDEN Academy

Concepts like real world data, federated data networks, and common data models can be challenging for non-experts to understand. To this end, the European Patients’ Forum (EPF) and EHDEN collaborated to create three introductory modules that aim to provide non-experts, particularly patients and citizens, with the knowledge they need to understand these terms. They will … Read more

EHDEN Contributor to Health Data Round Tables: 2020 – 2022

EHDEN was pleased to be a contributor to the series of Health Data Round Tables convened by the Digital Health Society (DHS) and the European Institute for Innovation through Health Data (i~HD), 2020 to date, and the following is their summary report with links to the round table reports: Health Data Round Tables Society needs … Read more

Erasmus MC, EHDEN Coordinator, contracted to establish DARWIN EU® Coordination Centre for the European Medicines Agency

The Erasmus University Medical Center (Erasmus MC) will work closely with the European Medicines Agency on the establishment of the Coordination Centre for the Data Analysis and Real World Interrogation Network (DARWIN EU®). The contract was awarded to Erasmus MC under the leadership of Professor Peter Rijnbeek, Chair of the Department of Medical Informatics, following … Read more

EHDEN project collaborating with the European Medicines Agency and partners to address COVID-19 in Europe

22nd July 2020, Brussels, Belgium. The Innovative Medicines Initiative (IMI) project, European Health Data & Evidence Network (EHDEN) is delighted to announce its involvement in establishing a European framework and research network for the conduct of multicentre cohort studies on the use of medicines in COVID-19 patients. The European Medicines Agency (EMA) has announced a … Read more

European Medicines Agency is an important partner in generating real world evidence.

Europe’s lead regulatory authority is very active in working with real work data (RWD) in its pursuit of its statutory goals of: Facilitate development and access to medicines Evaluate applications for marketing authorisation Monitor the safety of medicines across the life cycle Provide reliable information to patients and the public EMA is working towards and … Read more